首页> 外文OA文献 >Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
【2h】

Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.

机译:使用改良的口服液测定法对英国受试者的无细胞百日咳疫苗进行初次和学前疫苗接种后,对抗百日咳毒素IgG抗体衰减建模。

摘要

Recent vaccination with pertussis vaccine can confound serological and oral fluid (OF) assays targeting anti-pertussis toxin (anti-PT) IgG antibodies as a marker of recent infection. This study sought to establish the minimum potentially confounding time period based on experimental data to assist interpretation from such samples submitted from UK subjects for pertussis diagnosis. Anti-PT IgG antibody response and decay were measured post-vaccination using a modified OF IgG antibody-capture ELISA (GACELISA). Data were obtained from 72 infants after the third acellular pertussis vaccine dose in the primary schedule (4 months of age) and from 119 children after the single dose at preschool age (3 years 4 months to 5 years 8 months of age). Specimens were taken at approximately 1 month intervals for 9 months post-primary immunization (third dose) and 13 months post-preschool booster (PSB). The modified GACELISA demonstrated a sensitivity of 52/56 (92.9 %: 95 % CI 82.7-98.0) and a specificity of 120/128 (93.8 %: 95 % CI 88.0-97.3) and showed good agreement with the National Reference Laboratory standard anti-PT IgG serum ELISA (rank correlation = 0.80) and the original OF assay (rank correlation = 0.79). Modelling of the decline in antibody titres showed a reduction of 54 % and 34 % for each doubling of time after day 14 for the post-third primary dose and post-PSB subjects, respectively. These data suggest that the minimum confounding time period is approximately 300 days for samples obtained post-primary immunization and at least 3 years for samples submitted from UK children following immunization with the PSB. These data will greatly assist the interpretation of single high diagnostic anti-PT IgG titres by allowing an estimate of the positive predictive value, when the number of days post-immunization and prevalence are known or assumed.
机译:百日咳疫苗的近期疫苗接种可能会使针对抗百日咳毒素(anti-PT)IgG抗体的血清学和口腔液(OF)检测结果混淆,后者是近期感染的标志。这项研究试图根据实验数据确定最小的潜在混杂时间段,以帮助从英国受试者提交的用于百日咳诊断的样本中进行解释。疫苗接种后,使用改良的OF IgG抗体捕获ELISA(GACELISA)测量抗PT IgG抗体的应答和衰减。数据来自主要时间表中的第三次无细胞百日咳疫苗接种后的72例婴儿(4个月大)和学龄前(3岁4个月至5岁8个月)单剂后119例儿童。在初次免疫(第三次接种)后9个月和学龄前加强免疫(PSB)后的13个月,以大约1个月的间隔取样。改进的GACELISA的灵敏度为52/56(92.9%:95%CI 82.7-98.0),特异性为120/128(93.8%:95%CI 88.0-97.3),与美国国家参考实验室标准品抗-PT IgG血清ELISA(秩相关= 0.80)和原始OF分析(秩相关= 0.79)。抗体滴度下降的模型显示,对于第三个初次剂量和PSB后的受试者,在第14天后每增加一倍的时间分别减少54%和34%。这些数据表明,初次免疫后获得的样品的最小混淆时间约为300天,而PSB免疫后从英国儿童提交的样品的最小混杂时间至少为3年。当已知或假设免疫后天数和患病率很高时,这些数据将允许通过估计阳性预测值来极大地帮助解释单个高诊断性抗PT IgG滴度。

著录项

相似文献

  • 外文文献
  • 中文文献

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号